Wilson disease (WD) is a copper metabolism disorder characterized by hepatic and/or neurological damage. More than 200 mutations in the ATP7B gene causing this autosomal recessive defect have been reported. In certain populations, a high prevalence of particular mutations allows rapid screening and diagnosis of the disease. We identified the ATP7B alterations in Spanish patients with WD. Mutations in the ATP7B gene were analysed in a total of 64 individuals from 40 different WD families by PCR amplification, single-strand conformation polymorphism (SSCP) analysis and sequencing. Twenty-one different ATP7B gene mutations were identified, eight of which were novel. 74% of the disease alleles were characterized among the 40 unrelated probands. We identified a prevalent mutation in our population (Met645Arg), present in 55% of this 40 patients. The frequency of the remaining ATP7B alterations was low. In addition, 17 different polymorphic variants were found. There is remarkable allele heterogeneity in WD in the Spanish population. Nevertheless, SSCP screening for the most frequent mutations in our population is feasible and leads to the detection of about 74% of the mutated chromosomes. Molecular diagnosis of WD is very useful in clinical practice to confirm or support clinical suspicion.

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1399-0004.2005.00439.xDOI Listing

Publication Analysis

Top Keywords

atp7b gene
16
mutations atp7b
12
wilson disease
8
spanish population
8
atp7b alterations
8
mutations
6
atp7b
6
mutation analysis
4
analysis wilson
4
disease
4

Similar Publications

Hepatic progenitor cells reprogrammed from mouse fibroblasts repopulate hepatocytes in Wilson's disease mice.

Stem Cell Res Ther

March 2025

Liver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing, 100050, China.

Background: Wilson's disease (WD) is a genetic disorder that impairs the excretion of copper in hepatocytes and results in excessive copper deposition in multiple organs. The replacement of disordered hepatocytes with functional hepatocytes can serve as a lifelong therapeutic strategy for the treatment of WD. The aim of this study was to determine the hepatocyte repopulation effects of fibroblast-derived hepatic progenitor cells in the treatment of WD.

View Article and Find Full Text PDF

N,N'bis-(2-mercaptoethyl) isophthalamide (NBMI) as a novel chelator for Wilson's Disease.

Free Radic Biol Med

March 2025

Department of Pharmaceutical Sciences, MCPHS University, School of Pharmacy, Boston, MA, USA. Electronic address:

Wilson's Disease (WD) is a rare autosomal recessive disorder caused by mutations in the ATP7B gene. These mutations lead to defective copper (Cu) transport and to accumulation of Cu in tissues, primarily in the liver and brain. Current treatment options such as D-penicillamine, trientine, and zinc salts focus on increasing Cu excretion or reducing Cu absorption, but often cause debilitating side effects.

View Article and Find Full Text PDF

Mutations in the adenosine triphosphatase (ATPase) copper transporting beta (ATP7B) gene result in Wilson's disease (WD), a rare autosomal recessive condition that affects copper metabolism, leading to its accumulation in multiple tissues, including the liver and the brain. This case report details the clinical presentation of three siblings born out of a consanguineous marriage, each displaying different manifestations. The youngest sibling exhibited significant hepatic and neurological symptoms, the middle sibling experienced neuropsychiatric issues, and the eldest one initially showed psychological distress without classic symptoms of WD.

View Article and Find Full Text PDF

Background: Wilson's disease (WD) is an autosomal recessive inherited disease caused by ATP7B gene mutations. Some mutations in ATP7B are presumed to be pathogenic by altering pre-mRNA splicing, while most have not been functionally verified. This study aimed to perform functional studies to verify the pathogenicity of variants that may affect pre-mRNA splicing.

View Article and Find Full Text PDF

The accuracy and precision of quantitative aspects of conventional newborn screening (NBS) are limited due to the complexity of clinical manifestations and the constraints of conventional screening methods. Gene sequencing is commonly employed as an adjunct diagnostic technique to assist in diagnosis. The combined utilization of traditional NBS and newborn genetic screening can effectively reduce false-negative and false-positive rates, thereby enhancing the accuracy and precision of screening, while minimizing the health impact caused by genetic diseases in infants.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!